Poznan University of Medical Sciences
Poznan, Poznań, 61-701, Poland
NCT Number: NCT06233617
Effect of perineurial dexamethasone and dexmedetomidine on erector spinal plane block duration for spine surgery.
Looking for future studies?
Notify Me18 year–100 year
All sexes
Interventional
Phase 4
Poznan, Poznań, 61-701, Poland
This study is proposed to explore the effect of perineurial Dexamethasone and Dexmedetomidine on erector spinal plane block duration for spine surgery.
After spine surgery, patients need good analgesia. Peripheral nerve blocks have provided a safe, effective method to control early postoperative pain when symptoms are most severe.
The safety of local anaesthesia is essential due to the much lower toxicity threshold of local anaesthetics. An effective adjuvant, such as Dexamethasone or Dexmedetomidine, could allow for a higher dilution of local anaesthetics while maintaining and enhancing their analgesic effect.
There is considerable research where intravenous and perineural dexamethasone and Dexmedetomidine use have been compared in adults. However, there is a massive lack of research regarding spine surgery and the Erector Spinae Plane Block.
In this study, investigators compare perineural Dexamethasone and Dexmedetomidine.
The investigator aims to find a dexamethasone or dexmedetomidine that covers the need for good pain relief and fast recovery postoperatively.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
biliteral administration of 20ml of 0,2% ropivacaine + 2ml 0.9% sodium chloride for the erector spine plane block
Other names: 0.9% Sodium Chloride iv.
biliteral administration of 20ml of 0,2% ropivacaine with 4mg Dexamethasone for the erector spine plane block
Other names: 0,2% ropivacaine with 4mg Dexamethasone iv
biliteral administration of 20ml of 0,2% ropivacaine with 50ug Dexmedetomidine for the erector spine plane block
Other names: 0,2% ropivacaine with 50ug Dexmedetomidine
Time frame: 48 hours
Time after surgery when the patient needs opiate for the first time
Time frame: 48 hours
Total opiate consumption after surgery
Time frame: Time Frame: 4 hours after surgery
NRS (Numerical Rating Scale; 0 - no pain; 10 - the worst pain ever)
Time frame: Time Frame: 8 hours after surgery
NRS (Numerical Rating Scale; 0 - no pain; 10 - the worst pain ever)
Time frame: Time Frame: 12 hours after surgery
NRS (Numerical Rating Scale; 0 - no pain; 10 - the worst pain ever)
Time frame: Time Frame: 16 hours after surgery
NRS (Numerical Rating Scale; 0 - no pain; 10 - the worst pain ever)
Time frame: Time Frame: 20 hours after surgery
NRS (Numerical Rating Scale; 0 - no pain; 10 - the worst pain ever)
Time frame: Time Frame: 24 hours after surgery
NRS (Numerical Rating Scale; 0 - no pain; 10 - the worst pain ever)
Time frame: 48 hours after surgery
Neutrophil-to-lymphocyte ratio
Time frame: 48 hours after surgery
Platelet-to-lymphocyte ratio
Poznan University of Medical Sciences
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05345249
Bone Diseases, Fusion of Spine
Ubbergen, Gelderland, Netherlands
View Trial DetailsNCT05166018
Bone Diseases, Musculoskeletal Diseases
Bruges, New Aquitaine, France
View Trial DetailsNCT04166981
Bone Diseases, Musculoskeletal Diseases
Middelfart, Denmark
View Trial DetailsNCT04983576
Bone Diseases, Musculoskeletal Diseases
Bologna, BO, Italy
View Trial Details